Biogen Inc. (BIIB) operating KPIs
BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3061% above fair value
$253.62+3.97 (+1.59%)
Close on Oct 30, 2026Market cap $37.47BP/E 44.9Yield –
KPIs
Operating metrics that drive Biogen's business
Coming soon
This tab will track the numbers specific to Biogen's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.